Gene Expression Profile and Its Interpretation in Squamous Cell Lung Cancer |
Park, Dong-Yoon
(Digital Genomics, Inc.)
Kim, Jung-Min (Digital Genomics, Inc.) Kim, Ja-Eun (Digital Genomics, Inc.) Yoo, Chang-Hyuk (Digital Genomics, Inc.) Lee, Han-Yong (Digital Genomics, Inc.) Song, Ji-Young (Digital Genomics, Inc.) Hwang, Sang-Joon (Digital Genomics, Inc.) Yoo, Jae-Cheal (Digital Genomics, Inc.) Kim, Sung-Han (Digital Genomics, Inc.) Park, Jong-Ho (Dept. of thoracic surgery, Korea Cancer Center Hospital) Yoon, Jeong-Ho (Digital Genomics, Inc.) |
1 | Morita, S. et al. Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small cell lung cancer tissue: analysis by northern blotting and in situ hybridization. Int. J. Cancer 78, 286-292 (1999) |
2 | Wang, T. et al. Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis. Oncogene 19, 1519-1528 (2000) DOI |
3 | Heighway, J. et al. Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 21, 7749-7763 (2002). DOI ScienceOn |
4 | Nikolopoulos, S.N. et al. Integrin signaling promotes tumor angiogenesis. Cancer Cell 6, 471-483 (2004) DOI ScienceOn |
5 | Romain, S. et al. DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): association with flow cytometric s-phase fraction and relative prognostic importance in node-negative premenopausal patients. Int. J. Cancer 95, 56-61 (2001) DOI ScienceOn |
6 | Oguri, T. et al. Increased expression of the MRP5 gene is associated with exposure to platinum drugs in lung cancer. Int. J. Cancer 86, 95-100 (2000) DOI ScienceOn |
7 | Travazoie, S. et al. Systematic determination of genetic network architecture. Nat. Genet. 22, 281-285 (1999) DOI ScienceOn |
8 | Petroziello, J. et al. Suppression subtractive hybridization and expression profiling identifies a unique setof genes overexpressed in non-small cell lung cancer. Oncogene 23, 7734-7745 (2004) DOI ScienceOn |
9 | Hibi, K. et al. PGP9.5 as candidate tumor marker for non-small cell lung cancer. Am. J. Pathology 155, 711-715 (1999) DOI ScienceOn |
10 | Solmi, R. et al. Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR. Int. J. Oncology 25, 1049-1056 (2004) |
11 | Brechot, J.M. et al. Diagnostic and prognostic value of Cyfra 21-1 compared with other tumor markers in patients with non-small cell lung cancer: a prospective study of 116 patients. Eur. J. Cancer 33, 385-391(1997) DOI |
12 | Pastor, A. et al. Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis. Eur. Respir. J. 10, 603-609 (1997) |
13 | Yang, Y.H. et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15 (2002) DOI |
14 | Shaw, L.M. et al. Activation of phosphoinositide 3-OH kinase by the integrin promotes carcinoma invasion. Cell 91, 949-960 (1997) DOI ScienceOn |
15 | Vicent, S. et al. ERK1/2 is activated in non-small cell lung cancer and associated with advance tumours. Br. J. Cancer 90, 1047-1052 (2004) DOI ScienceOn |
16 | Kanehisa, M. et al. From genomics to chemical genomics:new developments in KEGG. Nucleic Acids Res. 34, D354-D357 (2006) DOI ScienceOn |
17 | Gene Ontology Consortium. The Gene Ontology (GO) database and information resource. Nucleic Acids Res. 32, D258-D261 (2004) DOI |
18 | Subramanian, A. et al. Gene set enrichment analysis:A knowledge-based approach for interpreting genome -wide expression profiles. Proc. Natl. Acad. Sci.U.S.A. 102, 15545-15550 (2005) |